Ignite Immunotherapy Patents – Insights & Stats (Updated 2023)

Ignite Immunotherapy has a total of 22 patents globally, out of which 3 have been granted. Of these 22 patents, more than 77% patents are active. The United States of America is where Ignite Immunotherapy has filed the maximum number of patents. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Ignite Immunotherapy.

Ignite Immunotherapy was founded in the year 2015. The company was created to find optimal gene and immunotherapy delivery vehicles to target cancer cells in a variety of patient populations with common metastatic tumor types. The company specializes in oncolytic virus design and development, cancer immunotherapy, gene therapy vector discovery, experimental cancer therapeutics, and biotech entrepreneurship.

Do read about some of the most popular patents of Ignite Immunotherapy which have been covered by us in this article and also you can find Ignite Immunotherapy patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ignite Immunotherapy patent portfolio.

How many patents does Ignite Immunotherapy have?

Ignite Immunotherapy has a total of 22 patents globally. These patents belong to 3 unique patent families. Out of 22 patents, 17 patents are active.

How Many Patents did Ignite Immunotherapy File Every Year?

Ignite Immunotherapy Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantIgnite Immunotherapy Applications FiledIgnite Immunotherapy Patents Granted
202312
202221
202019

How many Ignite Immunotherapy patents are Alive/Dead?

Worldwide Patents

Ignite Immunotherapy Patent Portfolio

How Many Patents did Ignite Immunotherapy File in Different Countries?

Ignite Immunotherapy Worldwide Patent Filing

Countries in which Ignite Immunotherapy Filed Patents

CountryPatents
United States Of America3
Taiwan2
Canada2
Europe2
Argentina2
Australia1
Brazil1
Russia1
India1
Hong Kong (S.A.R.)1
Japan1
Mexico1
Israel1

Where are Research Centers of Ignite Immunotherapy Patents Located?

The Research Centre for all the Ignite Immunotherapy patents is the United States of America.

Best Ignite Immunotherapy Patents

WO2021116943A1 is the most popular patent in the Ignite Immunotherapy portfolio. It has received 1 citation so far from company like Hangzhou Arnold Biomedical Technology Co Ltd.

List of Ignite Immunotherapy Patents

Ignite Immunotherapy PatentsTitle
US11685904B2Recombinant Vaccinia Virus And Methods Of Use Thereof
US11529402B2Recombinant Vaccinia Virus And Methods Of Use Thereof
US20230002740A1Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof
EP4073088A1Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof
EP3923967A1Recombinant Vaccinia Virus And Methods Of Use Thereof
CA3163805A1Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof
CA3129883A1Recombinant Vaccinia Virus And Methods Of Use Thereof
AU2020402303A1Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof
JP2022520220ARecombinant Vaccinia Virus And Method Of Use Thereof
HK40078852AVariant Oncolytic Vaccinia Virus And Methods Of Use Thereof
IN202217035312AVariant Oncolytic Vaccinia Virus And Methods Of Use Thereof
RU2805179C1Vaccine Oncolytic Version And Methods Of Its Use
AR122250A1Recombinant Vaccinia Virus And Methods Of Use Thereof
BR112022011158A2Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof
IL293627AVariant Oncolytic Vaccinia Virus And Methods Of Use Thereof
MX2022007237AVariant Oncolytic Vaccinia Virus And Methods Of Use Thereof.
AR117808A1Recombinant Vaccine Virus And Methods Of Use Thereof
WO2021116943A1Variant Oncolytic Vaccinia Virus And Methods Of Use Thereof
WO2020165730A1Recombinant Vaccinia Virus And Methods Of Use Thereof
WO2020148612A1Recombinant Vaccinia Virus And Methods Of Use Thereof
TW202102524ARecombinant Vaccinia Virus And Methods Of Use Thereof
TW202038994ARecombinant Vaccinia Virus And Methods Of Use Thereof

What are Ignite Immunotherapy key innovation segments?

What Technologies are Covered by Ignite Immunotherapy?

The chart below distributes patents filed by Ignite Immunotherapy in different countries on the basis of the technology protected in patents. It also represents the markets where Ignite Immunotherapy thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ignite Immunotherapy search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ignite Immunotherapy?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.